Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.60    -0.10 (-2.13%)
Bid:
4.56
Ask:
4.59
Spread: 0.03 (0.658%)
Market Cap: £220.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Fleet Product Launch

27 Apr 2015 07:00

RNS Number : 2486L
Seeing Machines Limited
27 April 2015
Β 

Seeing Machines Launches Fleet Product

New Lifesaving Technology Combats Distracted Driving and Fatigue

27 April 2015

CINCINNATI (NPTC ANNUAL CONFERENCE) - Seeing Machines (AIM: SEE), the AIM-listed company with a focus on operator monitoring and intervention sensing technologies and services, is pleased to announce the U.S. launch of Seeing Machines Fleet, an incident avoidance solution that helps drivers and fleet operators better manage fatigue and distraction events in real time.

Β 

Unlike today's common, in-cab video-based event recorders, Seeing Machines Fleet technology helps professional drivers avoid accidents and reduce the risk of governmental fines through an advanced set of distraction and fatigue detection technologies. Seeing Machines Fleet uses the company's proven computer-vision DSSβ„’ technology to track driver eye and facial movement to provide fleet operators an objective way of detecting and preventing driver fatigue and distraction events in real time. The moment a threat is detected, the system alerts the driver and the monitoring staff through in-vehicle alarms and seat vibrations while sending an informative data package to the central monitoring team for further analysis and action.

Β 

"Unlike competitors' passive recording technology that is used for post-event analysis and driver coaching, our technology assists operators and truck drivers in avoiding accidents in the first place. This has helped our customers reduce fatigue and distraction related incidents - helping keep people, cargo and equipment safe as well as increasing efficiency, productivity and profitability." said Ken Kroeger, CEO, Seeing Machines.

Β 

The research and development supporting Seeing Machines Fleet spans more than eight years of testing, field studies and industry usage in mining, transportation and automotive sectors where the organisation works closely with its alliance partners Caterpillar and Takata. The technology is currently being used by mining, road transport and bus customers in Europe, Australia and South Africa and is expected to appear in private passenger cars as early as 2016. Seeing Machines has shipped more than 4,000 units of its driver safety system worldwide, with all clients reporting, at minimum, a 71 percent reduction in fatigue and distraction related driving events.

Β 

The data shows an overwhelming need for increased safety on the roads. According to the U.S. National Highway Traffic Safety Administration (NHTSA), a high number of people are killed each year due to fatigue and distraction while driving. In 2012 alone, large trucks were involved in traffic accidents that injured 104,000 people in the U.S. According to Fleetistics, the average cost of a wrongful death verdict for trucking companies is US$6.7 million. Seeing Machines' solution enables operators to take direct action to reduce the number of accidents on the road.

Β 

"Driver fatigue and distraction are clearly major contributing factors in vehicle accidents. Drivers who are tired or who have microsleeps, or who are distracted by activities including texting, drift in and out of lanes or off the road, vary their speed unnecessarily and are fundamentally unable to react in time to other drivers and other potential hazards on the road." said Dr. Mike LennΓ©, GM Human Factors, Seeing Machines. "Seeing Machines has created an industry-leading portfolio of image processing capability related specifically to head, eye, and gaze tracking. This core technology is crucial in detecting these behaviours in real time and therefore in helping companies and drivers to better understand their safety issues and to support changes to address these known risks."

Β 

Β 

Enquiries:

U.S. Press

Anne Donohoe, Public Relations

Β 

Seeing Machines Limited

Β 

+01 732 620 0033

Anne.Donohoe@seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Christopher RaggettCorporate Finance

+44 20 7220 0500

Joanna Weaving, Corporate Broking

Β 

Newgate, Investment Communications for Seeing Machines

Robyn McConnachie

Β 

Tim Thompson

Β 

Lois Engstrand

Tel:Β +44 20 7653 9852 / Mob:Β +44 7540 706 191

Robyn.mcconnachie@newgatecomms.com

Tel: +44 20 7653 9858 / Mob: +44 7710 718 649

Tim.thompson@newgatecomms.com

Tel: +44 20 7653 9844 / Mob: +44 7540 248 478

Lois.engstrand@newgatecomms.com

About Seeing Machines

Seeing Machines, (AIM: SEE) is focused on operator monitoring and intervention sensing technologies and services. With more than 15 years of experience, Seeing Machines uses advanced detection and prevention safety assistance technologies to track eye and facial movement in order to monitor fatigue, drowsiness and distraction events, like microsleeps, texting and cell phone use as they occur, while providing for a real-time intervention strategy, which improves operator, driver and environmental safety, preserves assets, and reduces risk. Seeing Machines' technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia and has offices in Tucson, Arizona, Mountain View, California and Santiago, Chile. The Company has strategic alliances with Caterpillar, TK Holdings and Eye Tracking Inc and counts companies such as BHP Billiton, Freeport McMoran, Toll Holdings and Boeing amongst its customers.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAPLLASDSEEF
Date   Source Headline
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.